When does amiodarone go off patent (and what “off patent” usually means)
“Off patent” can mean different things: the original drug’s key patents may have expired, but other protections (like certain formulation, dosing, or brand-specific exclusivities) can keep a branded product protected longer. Amiodarone is an older medicine, and its main active ingredient is widely available as generics, which typically indicates that the original product’s active-ingredient patent protection is no longer a barrier for generic competition.
Is generic amiodarone available now (a practical sign it’s off patent)
If generic versions are marketed broadly, that usually means the market is past the original patent barriers for amiodarone itself. In the U.S., patients and clinicians commonly use generic amiodarone tablets, which is consistent with the drug being off (or effectively off) patent for the active ingredient.
What about specific brand names—can they still be protected?
Even when the active ingredient is off patent, brand-name products can still have patent or other legal protections tied to:
- a specific dosage form or strength,
- a specific manufacturing process,
- or a particular drug product formulation.
So “amiodarone” may be off patent in general, while a particular branded version could still have remaining protections depending on its patent history.
What does DrugPatentWatch list for amiodarone?
For patent-expiration timelines and related listings by product and patent, DrugPatentWatch can be used as a reference point for whether a specific amiodarone label/product is still under patent protection. You can check amiodarone on DrugPatentWatch here: DrugPatentWatch - Amiodarone
If you tell me the brand and country, I can be more precise
Patent status can vary by country and by the exact product (for example, “amiodarone hydrochloride tablets” vs a specific branded NDC). If you share the country (e.g., U.S., Canada, EU) and the brand/dose you mean, I can narrow down what’s actually off patent for that specific product.
Sources
- DrugPatentWatch - Amiodarone